Health December 19, 2022 Becton Dickinson recognizes TecSalud for vascular access management TecSalud has been internationally recognized by Becton Dickinson and the Infusion Nurses Society as a Center of Clinical Excellence for Vascular Access Management.
Research April 25, 2022 TecSalud conducts study with cannabidiol to treat COVID after-effects Specialists from TecSalud and the company Cardiol Therapeutics are researching the use of a molecule derived from cannabidiol (CBD) to treat COVID-19 patients.
Research December 22, 2021 TecSalud to carry out study for COVID-19 with cannabis derivative This is the first study approved by COFEPRIS to be carried out in Mexico with a cannabis plant derivative. TecSalud is the first Center approved for the study of medicinal CBD in Mexico.
Research October 08, 2021 Deciphering Mexican genome: challenge of oriGen project The oriGen project, an initiative TecSalud is participating in, hopes to crack the Mexican genome by studying 100,000 people to determine the genetic components associated with the population’s most common diseases.
Research October 01, 2021 TecSalud begins clinical trial of COVID antibody treatment TecSalud begins clinical trials of polyclonal antibodies to treat COVID-19 patients in collaboration with pharmaceutical company Inosan Biopharma.
Research July 21, 2021 Tec laboratory searches for variants of COVID-19 in wastewater The Tec de Monterrey Wastewater Monitoring Laboratory (MARTEC) is developing technology to detect new variants of the SARS-CoV-2 virus.
Research June 16, 2021 Patent created: Tec professors design ophthalmic device A portable ophthalmic device created by Tec academics that enables eye procedures to be performed in a sterile environment has already obtained a patent.
Research June 10, 2021 CureVac vaccine protocol: public-private collaboration success story Clinical trials for the CureVac vaccine carried out by private institutions such as TecSalud and the Mexican government have made public-private synergy necessary.
Research May 11, 2021 TecSalud will develop a protocol for cell therapy against COVID-19 TecSalud and NovocellBio signed a collaboration agreement to start the NK (natural killer) immune cell culture protocol.
Health February 17, 2021 TecSalud begins Phase 3 trials of German CureVac vaccine in Mexico TecSalud has started administering the vaccine candidate from German pharmaceutical company CureVac for its Phase 3 clinical trials.
